Deutsche Bank
CLSD

Deutsche Bank’s Clearside Biomedical CLSD Stock Holding History

Deutsche Bank’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,968
Closed -$509K – 4430
2021
Q2 		$509K Hold
6,968
– – ﹤0.01% 3212
2021
Q1 		$258K Buy
+6,968
New +$350K ﹤0.01% 3496
2019
Q3 		– Sell
-471
Closed -$6K – 4929
2019
Q2 		$6K Sell
471
-2,997
-86% -$53.4K ﹤0.01% 5060
2019
Q1 		$70K Sell
3,468
-32,316
-90% -$641K ﹤0.01% 4444
2018
Q4 		$573K Buy
35,784
+29,199
+443% +$1.37M ﹤0.01% 3240
2018
Q3 		$607K Buy
6,585
+2,900
+79% +$345K ﹤0.01% 3664
2018
Q2 		$591K Buy
3,685
+1,807
+96% +$305K ﹤0.01% 3754
2018
Q1 		$301K Sell
1,878
-1,290
-41% -$157K ﹤0.01% 3983
2017
Q4 		$331K Buy
3,168
+801
+34% +$86K ﹤0.01% 3800
2017
Q3 		$309K Sell
2,367
-5,595
-70% -$683K ﹤0.01% 3650
2017
Q2 		$1.09M Buy
7,962
+4,427
+125% +$532K ﹤0.01% 2979
2017
Q1 		$419K Buy
3,535
+2,518
+248% +$297K ﹤0.01% 3177
2016
Q4 		$134K Buy
1,017
+350
+52% +$87.9K ﹤0.01% 3918
2016
Q3 		$173K Buy
+667
New +$81.7K ﹤0.01% 3715

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's CLSD Position: Q3 2021 in Review

Deutsche Bank sold out of Clearside Biomedical (CLSD) in Q3 2021, closing a stake of 6,968 shares — an estimated $509K sold.

Deutsche Bank first reported a position in CLSD in Q3 2016 and held it in 14 quarters. The position peaked at $1.09M in Q2 2017. 65 funds tracked by Wall St. Rank hold CLSD as of Q3 2021.

  • Deutsche Bank reported no remaining Clearside Biomedical position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 6,968 Clearside Biomedical shares in Q3 2021, an estimated $509K.
  • Deutsche Bank first reported a position in Clearside Biomedical in Q3 2016 and held it in 14 quarters.
  • Deutsche Bank's Clearside Biomedical position peaked at $1.09M in Q2 2017.
  • 65 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.